MiniMed to announce financial results for its fourth quarter and full fiscal year 2026

Rhea-AI Summary

MiniMed (Nasdaq: MMED) will report fourth quarter and full fiscal year 2026 results on Wednesday, June 3, 2026. A news release will be issued at ~3:45 a.m. PDT and a webcast will follow at 5:45 a.m. PDT.

According to MiniMed, the fiscal year ends on April 24, 2026, and a replay and transcript will be posted within 24 hours at the company investor site.

News Market Reaction – MMED

+5.70%

2 alerts

+5.70% Session close to close

$4.35B Market Cap

0.7x Rel. Volume

In the Apr 14 session, MMED gained 5.70%, reflecting a notable positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.7% in the session following this news. A strong positive reaction aligns with ant...

Analysis

The stock moved +5.7% in the session following this news. A strong positive reaction aligns with anticipation around MiniMed’s first full reporting cycle as a standalone public company. The scheduled Q4 and FY 2026 release on June 3, 2026 follows recent milestones such as the IPO and MiniMed Flex™ clearance. Investors would need to weigh how much optimism had already been priced in and whether prior mixed reactions to good news signal potential for post-earnings volatility.

Key Figures

Earnings date: June 3, 2026 News release time: 3:45 a.m. PDT Webcast time: 5:45 a.m. PDT +2 more

5 metrics

Earnings date June 3, 2026 Scheduled Q4 and FY 2026 financial results release

News release time 3:45 a.m. PDT Planned time for earnings press release on June 3, 2026

Webcast time 5:45 a.m. PDT Scheduled webcast to discuss Q4 and FY 2026 results

Fiscal year end date April 24, 2026 End of MiniMed’s full fiscal year 2026

Webcast replay window 24 hours Replay and transcript expected within 24 hours of webcast

Historical Context

2 past events · Latest: 2026-03-18 (Positive)

Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
2026-03-18	Product FDA clearance	Positive	-0.2%	FDA cleared MiniMed Flex™ insulin pump with strong real‑world Time in Range data.
2026-03-09	IPO completion	Positive	+1.8%	Closing of IPO with 28M shares at $20 and ~$538M in net proceeds.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent major news showed a mixed pattern: one positive FDA clearance saw a slight negative reaction, while the IPO news aligned with a modest gain.

Recent Company History

Over recent months, MiniMed has transitioned to trading as an independent public company and advanced its diabetes technology pipeline. The IPO on March 6, 2026 raised substantial capital, and FDA clearance for MiniMed Flex™ on March 18, 2026 accelerated commercialization plans. Today’s earnings-date announcement fits into this sequence as the first scheduled report covering these post-separation developments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTHRIDGE, Calif., April 13, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2026 on Wednesday, June 3, 2026. A news release will be issued at approximately 3:45 a.m. Pacific Daylight Time (PDT) and will be available at https://news.minimed.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2026, which will end on Friday, April 24, 2026.

MiniMed will host a webcast at 5:45 a.m. PDT on June 3, 2026, to discuss results for its fourth quarter and full fiscal year 2026. The webcast can be accessed at https://investors.minimed.com.

Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investors.minimed.com.

About MiniMed
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we've pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.

Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minimed-to-announce-financial-results-for-its-fourth-quarter-and-full-fiscal-year-2026-302740889.html

SOURCE MiniMed

FAQ

When will MiniMed (MMED) report Q4 and full fiscal year 2026 results?

MiniMed will report results on Wednesday, June 3, 2026, via a news release and webcast. According to MiniMed, the company will issue a news release at approximately 3:45 a.m. PDT and host a webcast at 5:45 a.m. PDT to discuss results.

What time is the MiniMed (MMED) earnings webcast on June 3, 2026?

The MiniMed webcast is scheduled for 5:45 a.m. PDT on June 3, 2026 to discuss Q4 and fiscal 2026 results. According to MiniMed, the webcast link will be available at the company's investor site and a replay and transcript follow within 24 hours.

Where can investors access the MiniMed (MMED) June 3, 2026 news release and webcast?

Investors can access the news release at news.minimed.com and the webcast at investors.minimed.com. According to MiniMed, the release will be posted at ~3:45 a.m. PDT and the replay and transcript will be posted within 24 hours under Events.

What fiscal period does MiniMed's June 3, 2026 report cover for MMED?

The report covers the company's fourth quarter and full fiscal year 2026, which ends on April 24, 2026. According to MiniMed, the news release will include summary financial information for both the quarter and the full fiscal year.

Will MiniMed (MMED) provide a replay or transcript after the June 3, 2026 webcast?

Yes. A replay and transcript will be available within 24 hours of the webcast on the investor site. According to MiniMed, users can find the replay and transcript by clicking the Events link at investors.minimed.com.

How early will the MiniMed (MMED) news release be issued on June 3, 2026?

The company plans to issue the news release at approximately 3:45 a.m. Pacific Daylight Time on June 3, 2026. According to MiniMed, that release will include summary financial information for the fourth quarter and full fiscal year 2026.